Covid Treatment

Showing of 1 - 20 from 25 results
Covid Treatment - Total results - 25
COVID-19 treatment: Centre plans to create live dashboard to monitor availability of key drugs
India

COVID-19 treatment: Centre plans to create live dashboard to monitor availability of key drugs

The move is driven by the learnings from the second wave when COVID-19 critical medicines were hoarded and blackmarketed causing shortages in the market

Will poor countries get access to new antiviral medication to treat COVID or be elusive as vaccines?
World

Will poor countries get access to new antiviral medication to treat COVID or be elusive as vaccines?

The drugs work best if taken as soon as symptoms appear, and patients must be sure they have the coronavirus. But testing is scarce in many places.

Merck's new experimental pill can treat COVID-19, reduce hospitalisation and death by half
science

Merck's new experimental pill can treat COVID-19, reduce hospitalisation and death by half

A pill taken at home, by contrast, would ease pressure on hospitals and could also help curb outbreaks in poorer and more remote corners of the world that don’t have access to the more expensive infusion therapies.

AstraZeneca announces positive results from clinical trial of COVID-19 prevention drug
science

AstraZeneca announces positive results from clinical trial of COVID-19 prevention drug

This trial has 5,197 participants who had not been exposed and showed a 77-percent reduced risk of developing symptomatic disease with no severe cases recorded.

WHO's Solidarity trial will test three new potential COVID-19 drugs in new phase
science

WHO's Solidarity trial will test three new potential COVID-19 drugs in new phase

The study began in June 2021 and will continue till May 2022 and is being conducted in over 600 hospitals in 52 countries.

Study finds arthritis-treating drugs tocilizumab, sarilumab help reduce COVID-19 deaths
science

Study finds arthritis-treating drugs tocilizumab, sarilumab help reduce COVID-19 deaths

The analysis included information on 10,930 patients, of whom 6,449 were randomly assigned to receive interleukin-6 inhibitors and 4,481 to receive usual care or placebo.

Merck Pharma to sign licensing pacts with 5 Indian drug firms for COVID-19 drug candidate molnupiravir
India

Merck Pharma to sign licensing pacts with 5 Indian drug firms for COVID-19 drug candidate molnupiravir

Molnupiravir is an oral antiviral agent, currently being studied in a Phase 3 trial for the treatment of non-hospitalised COVID-19 patients

COVID-19 patients with high blood sugar at higher risk of death even if they don’t have diabetes, study suggests
Health

COVID-19 patients with high blood sugar at higher risk of death even if they don’t have diabetes, study suggests

Researchers have found that the cumulative probability of mortality was significantly higher in patients with hyperglycemia - whether they had diabetes or not - as compared to those with normal blood sugar levels

WHO chief Tedros Adhanom Ghebreyesus lauds Narendra Modi’s ‘strong commitment’ to COVID vaccine development
World

WHO chief Tedros Adhanom Ghebreyesus lauds Narendra Modi’s ‘strong commitment’ to COVID vaccine development

The PM and world health body chief discussed the value of traditional medicinal systems, with the latter appreciating India’s Ayushman Bharat scheme and campaign against tuberculosis

Timely treatment with tocilizumab likely to improve clinical outcomes in severe COVID-19 patients, finds study
Health

Timely treatment with tocilizumab likely to improve clinical outcomes in severe COVID-19 patients, finds study

The drug is already approved and is used for the treatment of rheumatoid arthritis, an autoimmune disease that leads to joint inflammation and pain

With over 90,000 new infections, India’s coronavirus tally surpasses Brazil’s 41 lakh cases
India

With over 90,000 new infections, India’s coronavirus tally surpasses Brazil’s 41 lakh cases

India has been recording the world’s largest daily coronavirus caseload for a month even as the government pushes to revive a contracting economy

Coronavirus cases in India surge past 35 lakh; recovery rate rises to 76.61%, over 4.14 cr samples tested
India

Coronavirus cases in India surge past 35 lakh; recovery rate rises to 76.61%, over 4.14 cr samples tested

It took 110 days for cases to reach one lakh, just 59 days more to go past the 10 lakh mark and by 23 August, India had reported 30 lakh infections

ICMR mulls setting up registry of hospitalised COVID-19 patients to collect data on response treatments
India

ICMR mulls setting up registry of hospitalised COVID-19 patients to collect data on response treatments

Fifteen institutions of national repute would be the registry sites and would mentor around 100 COVID-19 hospitals where the data would be collected

Mosquitoes cannot spread COVID-19, Kansas State University finds after studying three most common vectors species
Health

Mosquitoes cannot spread COVID-19, Kansas State University finds after studying three most common vectors species

Mosquitoes are common vectors of a number of infectious pathogens, but WHO has maintained that COVID-19 is a respiratory disease that spreads through droplets and fomites.

People more likely to contact COVID-19 at home than through outside contact, finds South Korean study
Health

People more likely to contact COVID-19 at home than through outside contact, finds South Korean study

Findings showed just 2 out of 100 people were infected from non-household contacts, with children under 9 years least likely to be the index patient

Human trials of Covaxin commence at Goa’s Redkar Hospital, to start in Odisha from Wednesday
India

Human trials of Covaxin commence at Goa’s Redkar Hospital, to start in Odisha from Wednesday

ICMR and Bharat Biotech are jointly working on the clinical development of Covaxin, which has received approvals for phase-I and phase-II human trials

Maharashtra makes Aadhaar card, positive test, doctor's prescription mandatory to buy COVID-19 drugs
India

Maharashtra makes Aadhaar card, positive test, doctor's prescription mandatory to buy COVID-19 drugs

The anti-viral drug remdesivir was cleared for 'restricted emergency use' to treat severe COVID-19 patients last month, causing a spike in demand for the medicine

COVID-19 Immunity: Lancet study suggests herd immunity may not be possible, antibodies found only in 5% of test population in Spain
Health

COVID-19 Immunity: Lancet study suggests herd immunity may not be possible, antibodies found only in 5% of test population in Spain

Herd immunity of importance as for the pandemic to be over, enough people in a community have to develop immunity against the coronavirus either after getting the disease or through vaccination

Mylan's remdesivir to cost Rs 4,800 per 100 mg vial in India, 80% cheaper than price tag in wealthy nations
Health

Mylan's remdesivir to cost Rs 4,800 per 100 mg vial in India, 80% cheaper than price tag in wealthy nations

Gilead priced remdesivir at $2,340 per patient for rich nations and agreed to send nearly all of its supply of the drug to the United States over the next three months

Human trials of Indian COVID-19 vaccine candidates mark ‘beginning of pandemic’s end’, writes Vigyan Parisar scientist
India

Human trials of Indian COVID-19 vaccine candidates mark ‘beginning of pandemic’s end’, writes Vigyan Parisar scientist

Aiming to launch a COVID-19 vaccine by 15 August, ICMR had written to select medical institutions to expedite clinical trials for the candidate COVAXIN